Mark Marzinke

Mark Marzinke

Johns Hopkins University

H-index: 47

North America-United States

Contact Mark Marzinke

About Mark Marzinke

Mark Marzinke, With an exceptional h-index of 47 and a recent h-index of 38 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of Clinical Chemistry, Mass Spectrometry, Clinical Pharmacology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021

Multiplexed quantification of venlafaxine and metabolites in human plasma by liquid chromatography-tandem mass spectrometry

Assessing Per-Sex-Act HIV-1 Risk Reduction Among Women Using the Dapivirine Vaginal Ring

Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)

Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017 …

Reply to Niu and Drain

Phase 1 randomized pharmacokinetic and safety study of a 90‐day tenofovir vaginal ring in the United States

Influence of Participant Perceptions of Adherence-Related Interactions with Study/Study Team on Drug Levels: HPTN069 Analysis of Self-Reported Adherence Experiences While on Study

Mark Marzinke Information

University	Johns Hopkins University
Position	School of Medicine
Citations(all)	10477
Citations(since 2020)	6909
Cited By	6185
hIndex(all)	47
hIndex(since 2020)	38
i10Index(all)	141
i10Index(since 2020)	126
Email	Access Email
University Profile Page	Johns Hopkins University
Google Scholar	View Google Scholar Profile

Mark Marzinke Skills & Research Interests

Clinical Chemistry

Mass Spectrometry

Clinical Pharmacology

Top articles of Mark Marzinke

Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021

Emerging Infectious Diseases

2024/2

Colleen F Kelley

H-Index: 25

David Metzger

H-Index: 29

Multiplexed quantification of venlafaxine and metabolites in human plasma by liquid chromatography-tandem mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

2024/6/15

Aashish Pandey

H-Index: 1

Nadia Ayala-Lopez

H-Index: 8

Claire E Knezevic

H-Index: 6

Assessing Per-Sex-Act HIV-1 Risk Reduction Among Women Using the Dapivirine Vaginal Ring

The Journal of Infectious Diseases

2024/4/15

Linda-Gail Bekker

H-Index: 66

Elizabeth R Brown

H-Index: 15

Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)

The Journal of Infectious Diseases

2023/11/29

Rebecca Giguere

H-Index: 14

Julie Elliott

H-Index: 10

Lin Wang

H-Index: 4

Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017 …

The Lancet HIV

2024/4/1

Ryan Milligan

H-Index: 17

Yu-Wei Lin

H-Index: 10

Reply to Niu and Drain

Clinical Infectious Diseases

2024/3/15

Phase 1 randomized pharmacokinetic and safety study of a 90‐day tenofovir vaginal ring in the United States

Journal of the International AIDS Society

2024/3

Barbra Richardson

H-Index: 42

Amanda Brown

H-Index: 14

Jennifer Robinson

H-Index: 14

Influence of Participant Perceptions of Adherence-Related Interactions with Study/Study Team on Drug Levels: HPTN069 Analysis of Self-Reported Adherence Experiences While on Study

AIDS and Behavior

2024/3

Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and …

The Lancet HIV

2023/12/1

Manya Magnus

H-Index: 30

Jorge Sanchez

H-Index: 3

Matthew A Spinelli

H-Index: 14

Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the …

The Lancet HIV

2023/11/1

Zhe Wang

H-Index: 3

Steven A Safren

H-Index: 61

Christina Psaros

H-Index: 26

Keren Middelkoop

H-Index: 23

Kenneth Mayer

H-Index: 15

Manya Magnus

H-Index: 30

Richard Novak

H-Index: 24

Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of the direct acting antivirals glecaprevir and pibrentasvir in plasma

Journal of Chromatography A

2014/2/7

Juan V Sancho

H-Index: 44

B-172 Development and Validation of an LC-MS/MS Assay for Quantification of Glecapravir/Pibrentasvir in Human Plasma

Clinical Chemistry

2023/10

Breakthrough HIV-1 infection in setting of cabotegravir for HIV pre-exposure prophylaxis

AIDS

2023/9/1

An introduction from the Laboratory Developed Tests special issue guest editors

Journal of Mass Spectrometry and Advances in the Clinical lab

2023/8

AACC/NKF guidance document on improving equity in chronic kidney disease care

The Journal of Applied Laboratory Medicine

2023/7

David Collister

H-Index: 11

Paul M Palevsky

H-Index: 41

Joseph Vassalotti

H-Index: 21

Preclinical considerations for long-acting delivery of tenofovir alafenamide from subdermal implants for HIV pre-exposure prophylaxis

Pharmaceutical Research

2023/7

Simon Webster

H-Index: 20

Joseph Kuo

H-Index: 1

Development and validation of a multiplexed assay for the measurement of long-acting hormonal contraceptives in plasma via liquid chromatography-tandem mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

2023/5/10

Claire E Knezevic

H-Index: 6

Aashish Pandey

H-Index: 1

Extended analysis of HIV infection in cisgender men and transgender women who have sex with men receiving injectable cabotegravir for HIV prevention: HPTN 083

Antimicrobial agents and chemotherapy

2023/4/18

Zhe Wang

H-Index: 3

Ryan Kofron

H-Index: 8

Lei Weng

H-Index: 13

Deborah Persaud

H-Index: 26

Kenneth Mayer

H-Index: 15

Correlates of self-reported and biomarker based adherence to daily oral HIV pre-exposure prophylaxis among a cohort of predominantly men who have sex with men in Nigeria

PloS one

2023/3/16

Mark Marzinke

H-Index: 30

Daniel Morgan

H-Index: 12

Jaih Craddock

H-Index: 8

Min Zhan

H-Index: 9

Stefan Baral

H-Index: 51

Inclusion of transgender and gender diverse people in phase III trials: examples from HIV pharmacologic prevention studies

2023/3

See List of Professors in Mark Marzinke University(Johns Hopkins University)

academic-engine

Useful Links

List of top 50 universities

List of top 100 universities

List of top 500 universities

Find Professors Email

Find Universities Email

CUFinder Academic Engine